A scientific reappraisal of the 'principle of similarity'

Medical Hypotheses

Volumn 49, Issue 3, 1997, Pages 203-212

  Bellavite, P ^a,b   Andrioli, G ^a   Lussignoli, S ^a   Signorini, A ^a   Ortolani, R ^a   Conforti, A ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL MEDICINE; CLINICAL RESEARCH; HISTORY OF MEDICINE; MEDICAL PRACTICE; PHILOSOPHY; PRIORITY JOURNAL; TRADITIONAL MEDICINE;

EID: 0030857331     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90204-8     Document Type: Article

References (60)

1. Boyd L J. A Study of the Simile in Medicine. Philadelphia: Boericke and Tafel, 1936.
2. The reference to Hippocrates is taken from Littre's Oeuvres Completes d'Hippocrates, Paris, 1939 (cited in ref. 1).
3. Miller A, Hafler D A, Weiner H L. Immunotherapy in autoimmune diseases. Curr Opin Immunol 1991; 3: 936-940.
4. MacDonald T T. Eating your way towards immunosuppression. Curr Biol 1994; 4: 178-181.
5. Weiner H L, Friedman H, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-837.
6. Hahnemann CFS. Versuch über ein neues Prinzip zur Auffindung der Heilkräfte der Arzneisubstanzen. Hufeland's Journal 1796; 2: 391-439.
7. Hahnemann C F S. Organon of Medicine. With explanations by Joseph Reves, edited from the 5th and 6th edition. Haifa: Homeopress, 1994.
8. Lux W. Isopathie der Contagionen. Liepzig: Ed. Kollmann, 1833.
9. Schulz H. Über die Theorie der Arzneimittelwirkung. Virchows Archiv 1877; 108: 423-434.
10. Schulz H. Über Hefegifte. Arch für Physiol 1888; 42: 517-541.
11. Martius F. Das Arndt-Schulz Grundgesetz. Münch Med Wschr 1923; 70: 1005-1006.
12. Oberbaum M, Cambar J. Hormesis: dose-dependent reverse effects of low and very low doses. In: Endler P C, Schulte J, eds. Ultra High Dilutions. Dordrecht: Kluwer, 1994: 5-18.
13. Townsend J F, Luckey T D. Hormoligosis in pharmacology. J Am Med Assoc 1960; 173: 44-48.
14. Stebbing A R D. Hormesis; the stimulation of growth by low levels of inhibitors. Sci Tot Environ 1982; 22: 213-234.
15. Furst A. Hermetic effects in pharmacology: pharmacological inversions as prototypes for hormesis. Health Phys 1987; 52: 527-530.
16. Calabrese E J, McCarthy M E, Kenyon E. The occurrence of chemically induced hormesis. Health Phys 1987; 52: 531-541.
17. Linde K, Jonas W B, Melchart D et al. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol 1994; 13: 481-492.
18. Bastide M. Immunological examples on ultra high dilution research. In: Endler P C, Schulte J, eds. Ultra High Dilutions. Dordrecht: Kluwer, 1994: 27-33.
19. Bellavite P, Signorini A. Homeopathy, a Frontier in Medical Science. Controlled Studies and Theoretical Foundations. Berkeley: North Atlantic Books, 1995.
20. Poitevin B, Davenas E, Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica. Br J Clin Pharmacol 1988; 25: 439-444.
21. Sainte-Laudy J, Belon P. Inhibition of human basophils activation by high dilutions of histamine. Agent Actions 1993; 38: C245-247.
22. Sainte-Laudy J, Belon P. Analysis of immunosuppressive activity of serial dilutions of histamine on human basophil activation by flow cytometry. Inflamm Res 1996; 45(S1): 33-34.
23. Bellavite P, Chirumbolo S, Lippi G et al. Homologous priming in chemotactic peptide stimulated neutrophils. Cell Biochem Funct 1993; 11: 93-100.
24. Bellavite P, Chirumbolo S, Lippi G et al. Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils. Cell Biochem Funct 1993; 11: 231-239.
25. Bellavite P, Carletto A, Biasi D et al. Studies of skin-window exudate human neutrophils: Complex patterns of adherence to serum-coated surfaces in dependence on FMLP doses. Inflammation 1994; 18: 575-587.
26. Iyengard R. Gating by cyclic AMP: expanded role for an old signaling pathway. Science 1996; 271: 461-463.
27. Wiegant F A C, van Wijk R. Self-recovery and the similia principle: an experimental model. Complem Ther Med 1996; 4: 90-97.
28. Wolff S. Are radiation-induced effects hermetic? Science 1989; 245: 575.
29. Luckey T D. Low-dose irradiation: Advantage east! Radiat Protect Management 1993; 10: 59-63.
30. Goldman M. Cancer risk of low-level exposure. Science 1996; 271: 1921-1822.
31. Lapp C, Wurmser L, Ney J. Mobilization de l'arsenic fixé chez le cobaye sous l'influence des doses infinitesimales d'arseniate. Therapie 1955; 10: 625-638.
32. Cambar J, Desmouliere A, Cal J C et al. Mise en évidence de l'effet protecteur de dilutions homéopathiques de Mercurius corrosivus vis-à-vis de la mortalité au chlorure mercurique chez la souris. Ann Homéopathiques Fr 1983; 5: 160-167.
33. Cazin J C, Cazin M, Gaborit J L et al. A study of the effect of decimal and centesimal dilutions of Arsenic on the retention and mobilisation of Arsenic in the rat. Human Toxicol 1987; 6: 315-320.
34. Palmerini C A, Codini M, Floridi A et al. The use of Phosphorus 30 CH in the experimental treatment of hepatic fibrosis in rats. In: Bornorini C, ed. Omeomed92. Bologna: Editrice Compositori, 1993: 219-226.
35. Ashby B. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Mol Pharmacol 1990; 38: 46-53.
36. Sergeeva M G, Gonchar M V, Grishina Z V, Mevkh A T, Varfolomeyev S D. Low concentrations of nonsteroidal anti-inflammatory drugs affect cell functions. Life Sci 1995; 56: 313-319.
37. Yankner B A, Duffy L K, Kirschner D A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 1990; 250-279-282.
38. Smith J A. Neutrophils, host defense, inflammation: a double-edged sword. J Leukoc Biol 1994; 56: 672-677.
39. Änggàrd E. Nitric oxide: mediator, murderer, medicine. Lancet 1994; 343: 1199-1206.
40. Skerret P J. Substance P causes pain, but also heals. Science 1990; 249: 625.
41. Adams D O, Hamilton T A. Macrophages as destructive cells in host defense. In: Gallin J I, Goldstein I M, Snyderam R, eds. Inflammation, 2nd edn. New York: Raven Press, 1992: 637-662.
42. Metz S A, Halter J B, Robertson R P. Paradoxical inhibition of insulin secretion by glucose in human diabetes mellitus. J Clin Endocrin Metab 1979; 48: 827-835.
43. Ludmer P L, Selwyn A P, Shook T L et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-1051.
44. Griffin J H. The thrombin paradox. Nature 1995; 378: 337-338.
45. Varela F J, Coutinho A. Second generation immune networks. Immunol Today 1991; 12: 159-166.
46. Segel L A, Jäger E, Elias E et al. A quantitative model of autoimmune disease and T-cell vaccination: does more mean less? Immunol Today 1995; 16: 80-84.
47. Conforti A, Lussignoli S, Bertani S et al. Intraperitoneal administration of adjuvant inhibits the development of adjuvant arthritis in rats. Int J Immunopathol Pharmacol 1995; 8(2): 113-121.
48. Scadding G K, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986; 16: 483-491.
49. Trentham D E, Dynesius-Trentham R A, Orav E J et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261: 1727-1730.
50. Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homoeopathy. Br Med J 1991; 302: 316-323.
51. Reilly D, Taylor M A, Beattie N G M et al. Is evidence for homoeopathy reproducible? Lancet 1994; 344: 1601-1606.
52. Jacobs J, Jimenez L M, Gloyd S S et al. Treatment of acute childhood diarrhea with homeopathic medicine: a randomized clinical trial in Nicaragua. Pediatrics 1994; 93: 719-725.
53. Koh Y Y, Lim H S, Min K U et al. Airways of allergie rhinitics are "primed" to repeated allergen inhalation challenge. Clin Exp Allergy 1994; 24: 347-353.
54. Brodde O E, Michel M C. Disease states can modify both receptor number and signal transduction pathways. Trends Pharm Sci 1989; 10: 383-384.
55. Nicolis G, Prigogine Y. Exploring Complexity. An Introduction. Munich: Piper, 1987.
56. Shinbrot T, Grebogi C, Ott E et al. Using small perturbations to control chaos. Nature 1993; 363: 138-140.
57. Mainzer K. Thinking in Complexity: The Complex Dynamics of Matter, Mind, Mankind. Berlin: Springer-Verlag, 1994.
58. Goldberger A L. Non-linear dynamics for clinicians: chaos theory, fractals, complexity at the bedside. Lancet 1996; 347: 1312-1314.
59. Brain P, Cousens R. An equation to describe dose-responses where there is stimulation of growth at low doses. Weed Res 1989; 29: 93-96.
60. Van Ewijk P H, Hoekstra J A. Calculation of the EC50 and its confidence interval when subtoxic stimulus is present. Ecotoxicol Environ Safety 1993; 25: 25-32.